Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 17, 2021 Filed Nov 19, 2021 09:53 UTC |
David Matthew TInterim CEO and CFO
|
PurchaseCommon Stock | 1,000 | $5.07 | $5,070.00 |
DisclosureSEC source: 0001213900-21-060724 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,150 Read SEC document |
| November 16, 2021 Filed Nov 19, 2021 16:45 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 10,000 | $5.14 | $51,400.00 |
DisclosureSEC source: 0001213900-21-060879 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,034 Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 19:52 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | Not disclosed | $0.00 Strike: $5.56 | $100,000.00 |
DisclosureSEC source: 0001213900-21-056529 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| November 01, 2021 Filed Nov 10, 2021 17:24 UTC |
David Matthew TInterim CEO and CFO
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $0.00 Strike: $5.56 | $0.00 |
DisclosureSEC source: 0001213900-21-058209 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Interim CEO and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2031-11-01 F1 · derivative.exercise_date: These options were granted on 11/1/2021. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:46 UTC |
Hurlburt ElizabethEVP, Head of Clinical Ops
|
SaleCommon Stock | 8,000 | $6.92 | $55,393.60 |
DisclosureSEC source: 0001213900-21-029080 · ownership.xml · nonDerivative · entry 1 Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.665 to $6.97. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 17, 2021 Filed May 19, 2021 17:40 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 15,000 | $6.03 | $90,477.00 |
DisclosureSEC source: 0001213900-21-027991 · ownership.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,034 F1 · price: This transaction was executed in multiple trades at prices ranging from $5.98 to $6.09. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 13, 2021 Filed May 20, 2021 16:18 UTC |
Nusbickel ThomasEVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 7,500 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001213900-21-028172 · ownership.xml · derivative · entry 2 Nusbickel Thomas · CIK 0001863281 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-05-13 F2 · derivative.exercise_date: These options were granted on May 13, 2021. These options shall vest in full on the first anniversary of the grant date, subject to continued employment. Read SEC document |
| May 13, 2021 Filed May 20, 2021 16:18 UTC |
Nusbickel ThomasEVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 260,000 | $0.00 Strike: $7.56 | $0.00 |
DisclosureSEC source: 0001213900-21-028172 · ownership.xml · derivative · entry 1 Nusbickel Thomas · CIK 0001863281 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 260,000 Underlying: Common Stock · 260,000 shares Expires 2031-05-13 F1 · derivative.exercise_date: The options vest as follows: 160,000 will vest over four years in four (4) equal installments on the first four anniversaries of May 13, 2021. The remaining 100,000 options vest on the achievement of certain milestones, subject to continued employment. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:00 UTC |
David Matthew TChief Financial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 80,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002050 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:03 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 140,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002052 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 01:07 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 320,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002054 · doc4.xml · derivative · entry 2 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:21 UTC |
Kaplan MyronDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002064 · doc4.xml · derivative · entry 2 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:16 UTC |
Dillione JanetDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002060 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 13, 2021 20:10 UTC |
Costa Paulo FDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002058 · doc4.xml · derivative · entry 1 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 02:39 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 140,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002078 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 02:35 UTC |
Hurlburt ElizabethEVP, Head of Clinical Ops.
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 140,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002076 · doc4.xml · derivative · entry 2 Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 140,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. These options vest, subject to continued employment, as follows: 50% of the options vest over time, with 25% vested on the grant date and 25% vesting in equal thirds on the first, second and third anniversaries of the grant date; and 50% of the options vest upon the achievement of certain milestones. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 01:27 UTC |
Lefkowitz Steven WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002066 · doc4.xml · derivative · entry 4 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F2 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 02:32 UTC |
DUNTON ALAN WDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002074 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 01:19 UTC |
Duncan Gregory ScottDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002062 · doc4.xml · derivative · entry 1 Duncan Gregory Scott · CIK 0001831127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| November 16, 2020 Filed Nov 18, 2020 16:16 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 3,583 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-037972 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,583 Underlying: Common Stock · 3,583 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:06 UTC |
Duncan Gregory ScottDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 2,500 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-20-035045 · doc4.xml · derivative · entry 2 Duncan Gregory Scott · CIK 0001831127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires 2030-11-02 F2 · derivative.exercise_date: These options were granted on 11/02/2020 and are subject to monthly vesting in equal installments during the one-year period beginning on December 2, 2020, subject to continued service on the board. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 22:06 UTC |
Duncan Gregory ScottDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-20-035045 · doc4.xml · derivative · entry 1 Duncan Gregory Scott · CIK 0001831127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-11-02 F1 · derivative.exercise_date: These options were granted on 11/02/2020. One-third of the options vested on the date of grant. One-third of the options will vest on each of the first and second anniversaries of the date of grant, subject to continued service on the board. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 08:38 UTC |
Costa Paulo FDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 3,750 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001213900-20-027050 · doc4.xml · derivative · entry 2 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 Underlying: Common Stock · 3,750 shares Expires 2030-09-15 F2 · derivative.exercise_date: These options were granted on 09/15/2020 and are subject to monthly vesting in equal installments during the one-year period beginning on October 15, 2020, subject to continued service on the board. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 08:38 UTC |
Costa Paulo FDirector
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.57 | $0.00 |
DisclosureSEC source: 0001213900-20-027050 · doc4.xml · derivative · entry 1 Costa Paulo F · CIK 0001465928 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-09-15 F1 · derivative.exercise_date: These options were granted on 09/15/2020. One-third of the options vested on the date of grant. One-third of the options will vest on each of the first and second anniversaries of the date of grant, subject to continued service on the board. Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 12:47 UTC |
Lefkowitz Steven WDirector
|
PurchaseCommon Stock | 2,215 | $3.98 | $8,815.70 |
DisclosureSEC source: 0001213900-20-025735 · doc4.xml · nonDerivative · entry 2 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,498 Read SEC document |
| September 04, 2020 Filed Sep 9, 2020 12:47 UTC |
Lefkowitz Steven WDirector
|
PurchaseCommon Stock | 3,500 | $4.00 | $14,000.00 |
DisclosureSEC source: 0001213900-20-025735 · doc4.xml · nonDerivative · entry 1 Lefkowitz Steven W · CIK 0001313149 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,283 Read SEC document |
| September 03, 2020 Filed Sep 8, 2020 08:38 UTC |
David Matthew TChief Financial Officer
|
PurchaseCommon Stock | 1,150 | $4.07 | $4,680.50 |
DisclosureSEC source: 0001213900-20-025532 · doc4.xml · nonDerivative · entry 1 David Matthew T · CIK 0001811612 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,150 Read SEC document |
| September 02, 2020 Filed Sep 4, 2020 08:25 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 15,300 | $4.27 | $65,358.54 |
DisclosureSEC source: 0001213900-20-025324 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,034 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.25 to $4.28. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:53 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 8,433 | $4.90 | $41,295.56 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 5 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,767 Read SEC document |
| August 19, 2020 Filed Aug 20, 2020 21:53 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 9,404 | $4.91 | $46,176.46 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 4 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,334 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 21,082 | $4.86 | $102,365.76 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 3 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,930 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 4,500 | $4.62 | $20,790.00 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 2 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,848 Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 21:53 UTC |
Khan MehmoodDirector
|
PurchaseCommon Stock | 2,331 | $4.60 | $10,722.60 |
DisclosureSEC source: 0001213900-20-023158 · doc4.xml · nonDerivative · entry 1 Khan Mehmood · CIK 0001505888 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,348 Read SEC document |
| August 14, 2020 Filed Aug 17, 2020 19:15 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 4,770 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-022574 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,770 Underlying: Common Stock · 4,770 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 10,000 | $4.35 | $43,460.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 3 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,878 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 7,500 | $4.14 | $31,050.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,878 Read SEC document |
| August 14, 2020 Filed Aug 18, 2020 00:06 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
PurchaseCommon Stock | 10,000 | $4.16 | $41,600.00 |
DisclosureSEC source: 0001213900-20-022579 · doc4.xml · nonDerivative · entry 1 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,378 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:08 UTC |
Mounts PhoebeGeneral Counsel
|
PurchaseCommon Stock | 2,525 | $4.03 | $10,175.75 |
DisclosureSEC source: 0001213900-20-022568 · doc4.xml · nonDerivative · entry 1 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 22:45 UTC |
Baluch KhosoDirector · Chief Executive Officer
|
PurchaseCommon Stock | 4,830 | $4.14 | $19,985.09 |
DisclosureSEC source: 0001213900-20-022546 · doc4.xml · nonDerivative · entry 1 Baluch Khoso · CIK 0001686223 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,905 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.1297 to $4.14. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 13, 2020 Filed Aug 17, 2020 19:02 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 15,000 | $4.08 | $61,159.50 |
DisclosureSEC source: 0001213900-20-022562 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,734 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.04 to $4.0899. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:29 UTC |
DUNTON ALAN WDirector
|
PurchaseCommon Stock | 5,000 | $3.95 | $19,750.00 |
DisclosureSEC source: 0001213900-20-022353 · doc4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Read SEC document |
| May 15, 2020 Filed May 18, 2020 16:20 UTC |
Kaplan MyronDirector
|
PurchaseCommon Stock | 10,000 | $3.85 | $38,500.00 |
DisclosureSEC source: 0001213900-20-012822 · doc4.xml · nonDerivative · entry 1 Kaplan Myron · CIK 0001672645 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,734 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.8199 to $3.88. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| May 15, 2020 Filed May 18, 2020 16:27 UTC |
Dillione JanetDirector
|
GrantPhantom Stock · Derivative | 5,253 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-012825 · doc4.xml · derivative · entry 2 Dillione Janet · CIK 0001489798 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,253 Underlying: Common Stock · 5,253 shares Expires not disclosed F1 · derivative.exercise_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. F1 · derivative.expiration_date: Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:18 UTC |
David Matthew TEVP, Chief Financial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $4.08 Strike: $4.08 | $510,000.00 |
DisclosureSEC source: 0001213900-20-011996 · doc4.xml · derivative · entry 2 David Matthew T · CIK 0001811612 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:18 UTC |
David Matthew TEVP, Chief Financial Officer
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 125,000 | $5.63 Strike: $5.63 | $703,750.00 |
DisclosureSEC source: 0001213900-20-011996 · doc4.xml · derivative · entry 1 David Matthew T · CIK 0001811612 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:30 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 50,000 | $4.08 Strike: $4.08 | $204,000.00 |
DisclosureSEC source: 0001213900-20-012005 · doc4.xml · derivative · entry 3 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 16:30 UTC |
Mounts PhoebeGeneral Counsel
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 50,000 | $5.63 Strike: $5.63 | $281,500.00 |
DisclosureSEC source: 0001213900-20-012005 · doc4.xml · derivative · entry 2 Mounts Phoebe · CIK 0001777330 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:44 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $4.08 Strike: $4.08 | $153,000.00 |
DisclosureSEC source: 0001213900-20-012021 · doc4.xml · derivative · entry 3 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:44 UTC |
ARMSTRONG JR. JOHN L.Exec VP of Tech Operations
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $5.63 Strike: $5.63 | $211,125.00 |
DisclosureSEC source: 0001213900-20-012021 · doc4.xml · derivative · entry 2 ARMSTRONG JR. JOHN L. · CIK 0001268675 · Exec VP of Tech Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:36 UTC |
Hurlburt ElizabethEVP, Head of Clinical Ops.
|
GrantStock Option (Right to Buy Common Stock) · Derivative | 37,500 | $4.08 Strike: $4.08 | $153,000.00 |
DisclosureSEC source: 0001213900-20-012013 · doc4.xml · derivative · entry 3 Masson-Hurlburt Elizabeth · CIK 0001735256 · EVP, Head of Clinical Ops. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 37,500 shares Expires 2030-05-11 F1 · derivative.exercise_date: These options were granted on 05/11/2020. These options vest 1/4 on the date of grant, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.